Contrast-associated acute kidney injury

1. GLP-1 receptor agonists are associated with contrast-associated acute kidney injury in humans (3.8% versus 4.5%; OR 0.84, 95% CI 0.71–0.99; absolute risk difference 0.7 percentage points).

   “CA-AKI occurred in 3.8% of GLP-1 RA users versus 4.5% of non-users after CE-CT”

   HumansType 2 diabetes and chronic kidney disease; after contrast-enhanced computed tomographykidneywithin three days after imaging

   GLP-1 receptor agonist use and contrast-associated acute kidney injury after contrast-enhanced CT and CT angiography in adults with type 2 diabetes and chronic kidney disease: a propensity score-matched cohort study

   Acta diabetologica·16 Oct 2026

More on GLP-1 receptor agonists